Dashboard
Manage Tickers

NUWE Nuwellis, Inc.

Nasdaq nuwellis.com


$ 2.45 $ -0.18 (-6.77 %)    

Thursday, 13-Nov-2025 11:22:23 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.53 $ -6.25 (-1.01 %)
DIA $ 478.38 $ -3.07 (-0.64 %)
SPY $ 675.66 $ -4.99 (-0.73 %)
TLT $ 89.83 $ 0.03 (0.03 %)
GLD $ 386.48 $ -0.83 (-0.21 %)
$ 2.67
$ 2.66
$ 2.45 x 100
$ 2.50 x 570
$ 2.48 - $ 2.57
$ 2.60 - $ 83.16
86,092
na
nm
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-11-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-11-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-03-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-03-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
20 03-25-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-05-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 02-21-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-22-2018 12-31-2017 10-K
33 11-02-2017 09-30-2017 10-Q
34 08-10-2017 06-30-2017 10-Q
35 05-12-2017 03-31-2017 10-Q
36 03-08-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-11-2016 06-30-2016 10-Q
39 05-05-2016 03-31-2016 10-Q
40 03-15-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nuwellis-q3-eps-056-beats-041-estimate-sales-2217m-miss-2500m-estimate
Nuwellis Q3 EPS $0.56 Beats $(0.41) Estima...
11/12/2025 13:18:18

Nuwellis (NASDAQ:NUWE) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $(0.41) by 2...

earnings-scheduled-for-november-12-2025
Earnings Scheduled For November 12, 2025
11/12/2025 11:11:28

nuwellis-receives-notice-of-allowance-for-new-patent-covering-advanced-safety-mechanisms-for-blood-return-line-clamps-used-in-extracorporeal-blood-filtration-systems-including-vivian-pediatric-crrt-system
Nuwellis Receives Notice Of Allowance For ...
11/10/2025 14:09:50

Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal con...

top-stocks-with-earnings-this-week-plug-oklo-circle-and-more
Top Stocks With Earnings This Week: Plug, ...
11/10/2025 13:38:37

Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, P...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/31/2025 17:06:11

robert-b-scott-resigns-as-cfo-of-nuwellis-john-l-erb-appointed-interim-cfo
Robert B. Scott Resigns As CFO Of Nuwellis...
10/08/2025 21:17:10

https://www.sec.gov/Archives/edgar/data/1506492/000114036125037713/ef20056785_8k.htm

nuwellis-announces-findings-from-ultra-peds-registry-study-examining-real-world-use-of-aquadex-system-in-children-with-aki-fluid-overload-or-congenital-kidney-failure
Nuwellis Announces Findings From ULTRA-Ped...
09/30/2025 12:51:43

ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill c...

nuwellis-secures-us-patent-for-hemolysis-sensor-technology-in-blood-filtration-systems-supporting-pediatric-device-vivian-and-platform-innovation
Nuwellis Secures U.S. Patent For Hemolysis...
09/18/2025 13:03:32

Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. ...

nuwellis-will-be-issued-us-patent-number-12415021-tomorrow-titled-extracorporeal-blood-filtering-machine-and-methods-for-treatment-of-fluid-overload
Nuwellis Will Be Issued U.S. Patent Number...
09/15/2025 19:51:28

nuwellis-development-partner--koronis-biomedical-technologies-corporation-awarded-3m-nih-grant-to-accelerate-vivian
Nuwellis' Development Partner, Koronis Bi...
09/09/2025 13:02:41

nuwellis-new-dual-lumen-extend-length-catheter-secures-fda-510k-clearance
Nuwellis' New Dual Lumen Extend Length Cat...
08/21/2025 12:16:27

nuwellis-signs-loi-to-acquire-rendiatech-advancing-renal-monitoring-capabilities-beyond-ultrafiltration-deal-expected-to-close-in-q4-2025
Nuwellis Signs LOI To Acquire Rendiatech, ...
08/19/2025 12:17:59

Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal h...

nuwellis-q2-eps-6099-versus-79182-last-year-sales-1725m-down-from-2194m-yoy
Nuwellis Q2 EPS $(60.99) Versus $(791.82) ...
08/14/2025 12:24:26

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/14/2025 12:08:55

Core News & Articles
Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

an-overview-of-nuwelliss-earnings
An Overview of Nuwellis's Earnings
08/13/2025 16:02:02

nuwellis-to-exit-international-operations-and-focus-exclusively-on-us-market
Nuwellis To Exit International Operations ...
08/07/2025 12:16:25

nuwellis-announces-it-has-postponed-its-q2-2025-earnings-release-and-conference-call-to-august-14-2025
Nuwellis Announces It Has Postponed Its Q2...
08/06/2025 12:21:15

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 17:06:56

nuwellis-announces-first-patients-have-been-successfully-treated-with-aquadex-ultrafiltration-therapy-in-a-hospital-based-outpatient-setting
Nuwellis Announces First Patients Have Bee...
08/05/2025 12:17:32

 Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company dedicated to transforming fluid management, today announced that th...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION